NASDAQ
Awakn Life Sciences Corp. (AWKNF) has a free cash flow growth of -17458.51% as of Friday, May 29, 2026. This represents a 34780.66% decrease compared to its 12-month average of -50.05%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.